Mr. Mark P. Carthy is a Senior Partner at Orion Healthcare Equity Partners. Mr. Carthy is a Founder and Managing Partner at Orion Equity Partners, LLC. He co-founded Orion Equity Partners, LLC in 2008. He is employed at Walnut Venture Associates. He served as a General Partner at Oxford Bioscience Partners IV, L.P. and Oxford Bioscience Partners V, L.P. He served as Biotechnology Portfolio Manager at Morningside Group (Holdings) Limited. He served as a General Partner at Oxford Bioscience Partners since 2001. He joined Oxford Bioscience Partners in October 2000. From 1998 to 2000, he was an Advisor to Kummell Investments Limited. He was the Chief Business Officer of Cubist Pharmaceuticals, Inc. Mr. Carthy served as a Senior Director of Business Development at Vertex Pharmaceuticals Incorporated. He serves as Chairman of Artesian Therapeutics, Inc. Mr. Carthy serves as Chairman of Cyberkinetics Neurotechnology Systems Inc., and has been its Director since August 2002. He has been a Director of Rexahn Pharmaceuticals, Inc., since March 3, 2014.
Mr. Carthy serves as Non Executive Director of PowderMed Ltd. He serves as Director of Scion Pharmaceuticals, Inc., Xanathus Life Sciences, Ensemble Discovery Corp., Lynx Therapeutics Inc., Ensemble Therapeutics Corporation and Cyberkinetics. He serves as Member of the Board of Directors of Slater Center for Biomedical Technology. Mr. Carthy served as a Director of Astex Therapeutics Limited. He served as a Director of Solexa Inc., since March 4, 2005. He served as a Director of Variagenics, Inc., Edusa Pharmaceuticals, Inc., Xanthus Pharmaceuticals, Inc., ImpactRx, Inc. and Dendreon Corp. He served as a Director of Affinium Pharmaceuticals, Ltd. since 2007. He is an elected Town Meeting Member and Library Trustee. He was listed on the Forbes 2009 Midas List as one of the leading venture capitalists. He holds an M.B.A. from Harvard Business School in 1987, an M.S. in Chemical Engineering from University of Missouri, and a B.E. in Chemical Engineering from University College Dublin, Ireland.